Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis ; volume:10 ; number:04 ; year:2020 ; pages:232-240
Avicenna journal of medicine ; 10, Heft 04 (2020), 232-240
- Contributor
-
Moustafa, Abdelmoniem
Khan, Mohammad
Saud, Marei
Abdalla, Alsamman Mohd
Amer, Baig
Muhammad, Saad
- DOI
-
10.4103/ajm.ajm_40_20
- URN
-
urn:nbn:de:101:1-2021090814033640385152
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moustafa, Abdelmoniem
- Khan, Mohammad
- Saud, Marei
- Abdalla, Alsamman Mohd
- Amer, Baig
- Muhammad, Saad
Other Objects (12)
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy
Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community